biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
antigen ~40 kDa
species reactivity
mouse, human, rat
concentration
~1.5 mg/mL
technique(s)
immunohistochemistry: 5-10 μg/mL using formalin-fixed, paraffin-embedded human breast carcinoma., immunoprecipitation (IP): 5-10 μg using extracts of HEK-293T cells., indirect immunofluorescence: 8-16 μg/mL using PC12 cells., western blot: 1.5-3.0 μg/mL using NIH3T3 cell extracts.
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... AKT1S1(84335)
mouse ... Akt1s1(67605)
rat ... Akt1s1(292887)
General description
Proline-rich Akt-substrate of 40 kDa (PRAS40) is a raptor binding protein. PRAS40 contains a target of rapamycin (TOR) signaling (TOS) motif.
Immunogen
synthetic peptide corresponding to a sequence at the C-terminus of human PRAS40, conjugated to KLH. The corresponding sequence is identical in mouse and rat PRAS40.
Application
Anti-PRAS40 (C-terminal) antibody is suitable for use in western blot (1.5-3.0 μg/mL using NIH3T3 cell extracts) and indirect immunofluorescence (8-16 μg/mL using PC12 cells). The product may also be used for immunoprecipitation (5-10 μg using extracts of HEK-293T cells) and immunohistochemistry (5-10 μg/mL using formalin-fixed, paraffin-embedded human breast carcinoma tissues).
Biochem/physiol Actions
Anti-PRAS40 (C-terminal) antibody is specific for human, mouse and rat PRAS40. In Immunoblotting, detection of the PRAS40 band is specifically inhibited by the PRAS40 immunizing peptide.
Proline-rich Akt-substrate of 40 kDa (PRAS40) inhibits mammalian target of rapamycin complex 1(mTORC1) kinase activity. It is involved in the PI3KAkt/protein kinase B (PKB) survival pathway. Phosphorylation of PRAS40 by Akt and mTORC1 disrupts the binding between mTORC1 and PRAS40 and relieves the inhibitory effect of PRAS40 on mTORC1 activity. The binding of PRAS40 to 14-3-3 requires amino acids and insulin, which is partially inhibited by rapamycin. PRAS40 is a component of the mTORC1 protein complex, which inhibits cell growth in insulin deprived cells. Furthermore, during nutrient or serum deprivation, PRAS40 binds mammalian target of rapamycin (mTOR) and inhibits insulin-stimulated mTOR signaling. PRAS40 activation has also been implicated in pulmonary and breast carcinogenesis. Thus, PRAS40 may be considered as a target protein for treating insulin resistance and various cancers.
Physical form
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
常规特殊物品
此项目有
Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms
Dunlop EA and Tee AR
Cellular Signalling, 21(6), 827-835 (2009)
Bei Huang et al.
Acta pharmacologica Sinica, 26(10), 1253-1258 (2005-09-22)
To study the expression of proline-rich Akt-substrate PRAS40 in the cell survival pathway and tumor progression. The effects of three key kinase inhibitors on PRAS40 activity in the cell survival pathway, serum withdrawal, H(2)O(2) and overexpression of Akt were tested.
Yasemin Sancak et al.
Molecular cell, 25(6), 903-915 (2007-03-28)
The heterotrimeric mTORC1 protein kinase nucleates a signaling network that promotes cell growth in response to insulin and becomes constitutively active in cells missing the TSC1 or TSC2 tumor suppressors. Insulin stimulates the phosphorylation of S6K1, an mTORC1 substrate, but
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持